Materiały źródłowe

• #1 Macular Degeneration: Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/15246-macular-degeneration

  Macular degeneration is primarily an age-related retinal condition. There are treatments, but there isn’t a cure. […] Starting treatments early can slow the progression of the disease and make symptoms less severe. Even with successful treatments, symptoms often return. Depending on the disease type, treatments include nutritional supplements, medications, photodynamic therapy (PDT) and laser therapy. […] The Age-Related Eye Disease Studies (AREDS and AREDS2) found that a combination of vitamins and minerals might slow the progression of dry AMD. […] There are drugs that treat but don’t cure wet AMD. They include anti-vascular endothelial growth factor (anti-VEGF) injections. […] During photodynamic therapy (PDT), your eye care specialist uses a combination of an injectable light-sensitive drug and a laser to destroy extra blood vessels in your eye.

• #1 Age-Related Macular Degeneration (AMD) | National Eye Institute

  https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration

  Treatment for AMD depends on the stage and type. Theres currently no treatment for early AMD, so your eye doctor will probably just keep track of how your eyes are doing with regular eye exams. Eating healthy, getting regular exercise, and quitting smoking can also help. […] If you have intermediate AMD in 1 or both eyes, special dietary supplements (vitamins and minerals) may be able to stop it from turning into late AMD. If you have late AMD in only 1 eye, these supplements may slow down AMD in your other eye. […] If you have wet AMD, there are other treatments that may be able to stop further vision loss: Medicines called anti-VEGF drugs that the doctor injects in your eye, Photodynamic therapy (PDT), a combination of injections and laser treatment. […] Theres currently no treatment for late dry AMD but researchers are hard at work looking for treatment options.

• #1 Dry macular degeneration – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/dry-macular-degeneration/diagnosis-treatment/drc-20350381

  For now, there’s no way to reverse damage from dry macular degeneration. However, there are many clinical trials in progress. If the condition is diagnosed early, you can take steps to help slow its progression, such as taking vitamin supplements, eating healthy and not smoking. […] For people with intermediate or advanced disease, taking a high-dose formulation of antioxidant vitamins and minerals may help reduce the risk of vision loss. […] The evidence doesn’t show benefit in taking these supplements for people with early-stage dry macular degeneration. Ask your eye doctor if taking supplements is right for you. […] Age-related macular degeneration doesn’t affect your side vision and typically doesn’t cause total blindness. But it can reduce or eliminate central vision. […] For some people with advanced dry macular degeneration in both eyes, an option to improve vision may be surgery to implant a telescopic lens in one eye. The telescopic lens, which looks like a tiny plastic tube, has lenses that magnify your field of vision. The telescopic lens implant may improve both distance and close-up vision, but it has a very narrow field of view.

• #1 Eyes – age-related macular degeneration | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/age-related-macular-degeneration

  Laser treatment this technique seals and destroys the leaking blood vessels. It may be recommended if the leaking blood vessels are located away from the centre of the macula. […] Photodynamic therapy a light-sensitive drug is injected into the veins in the arm and a specially designed laser is used to close off abnormal blood vessels in the retina. […] Various options are available to help manage AMD, including: Vision aids such as prescription glasses, magnifying glasses and telescopic devices to help the person live a more normal life. […] Occupational therapy can help the person to live a more independent life. […] Quitting smoking cigarette smoking contributes to the onset of AMD and can hasten its progression. It is important to stop smoking immediately. […] Lifestyle changes suggestions include eating a healthy diet and exercising regularly.

• #1 Age-related Macular Degeneration: Causes and Treatment

  https://www.aarp.org/health/conditions-treatments/early-signs-of-macular-degeneration/

  An essential part of any treatment plan no matter the stage or form of AMD is a healthy lifestyle, including regular exercise and a diet that incorporates plenty of fish and leafy green vegetables. Research published in American Journal of Ophthalmology suggests exercise helps guard against AMD. […] And a review of studies published in 2021 in the journal Clinical Nutrition showed that regularly eating fish, especially fatty fish like salmon, tuna, sardines, mackerel and herring which are high in omega-3 fatty acids, can reduce your risk of developing AMD. […] Although there’s no cure for macular degeneration, there are things you can do to slow its progression. […] Research, including a recent review of studies published in the journal Ophthalmology, shows that taking high-dose vitamins and minerals specifically, vitamins C and E, zinc, lutein, zeaxanthin, beta-carotene and copper slows progression of the disease in people with intermediate AMD and those with late-stage dry AMD.

• #1 Age-Related Macular Degeneration (AMD): Bausch + Lomb

  https://www.bausch.com/patient-resources/age-related-macular-degeneration/

  Much like the symptoms of AMD, the treatment options depend on the stage and type. […] There is currently no known treatment for early AMD, so your doctor may recommend regular exams to monitor the condition of your eyes. […] For individuals with a lot of drusen or with serious vision loss, taking a certain combination of nutritional supplements may prove beneficial. The specific formula of eye vitamins used in the AREDS and AREDS2 studies has been shown to help reduce the risk of progression in patients with moderate to advanced AMD. […] Studies show that eating healthy foods (such as dark leafy greens, fish and yellow fruits and vegetables) as well as taking regular exercise are beneficial to individuals with AMD. […] Wet AMD may be treated with medications called anti-VEGF drugs. Anti-VEGF injections can help reduce the number of abnormal blood vessels in the retina and slow any leaking from those vessels. […] Photodynamic therapy (PDT) a combination of injections and laser treatment may be used to treat certain types of wet AMD. Laser treatment also reduces the number of blood vessels while slowing any leaking.

• #1 Age-related Macular Degeneration: Causes and Treatment

  https://www.aarp.org/health/conditions-treatments/early-signs-of-macular-degeneration/

  Wet AMD is treated with the same AREDS2 vitamins as dry AMD but also with injections of medications into the eye to treat the leaking blood vessels, Andreoli says. […] Currently, these treatments are focused on stopping progression of disease, but good treatments that reverse damage are still in the works, she says. […] Laser photocoagulation is a form of surgery in which an eye care provider uses a special lens to focus an intense beam of light to seal off leaky blood vessels in the eyes. This can prevent more vision loss. The procedure is only done for wet AMD and is not appropriate for all patients. […] For those who have been diagnosed with AMD, reducing exposure to sunlight by wearing sunglasses, avoiding cigarette smoke, eating a healthy diet and getting annual eye exams can help lower the risk that a patient develops vision loss from AMD as they get older, Sodhi says.

• #1 Age-Related Macular Degeneration Treatment

  https://www.webmd.com/eye-health/macular-degeneration/age-related-macular-degeneration-treatment

  There’s no cure, but treatment for age-related macular degeneration (AMD) may slow the disease and keep you from having serious loss of vision. […] An early diagnosis will let you start treatment that may delay some symptoms or make them less serious. […] AREDS. A large National Eye Institute study called AREDS (Age-Related Eye Disease Study), shows benefits in intermediate- or late-stage AMD if you take a nutritional supplement. […] Anti-angiogenic drugs. If you have the wet form of AMD, your doctor will inject these medications into your eye. They stop new blood vessels from forming and stop the leaking from the abnormal vessels that cause wet AMD. […] Some people who get these drugs have been able to regain vision that they lost from AMD. You may need to repeat the treatment on follow-up visits.

• #1 Macular Degeneration | AOA

  https://www.aoa.org/healthy-eyes/eye-and-vision-conditions/macular-degeneration

  In a large human clinical trial, Age-Related Eye Disease Study (AREDS2) by the National Eye Institute Researchers, linked lutein and zeaxanthin, omega 3, vitamin C, vitamin E and zinc to reducing the risk of AMD. […] Scientific evidence suggests vitamin C, when taken with other essential nutrients, can slow the progression of AMD and visual acuity loss. […] AREDS showed that taking 400 IU/day of vitamin E, along with antioxidants beta-carotene, vitamin C and zinc supplementation, slows the progression of AMD by about 25% in individuals at high risk for the disease. […] AREDS showed that taking 40-80 mg/day of zinc, along with antioxidants beta-carotene, vitamin E and vitamin C, slows the progression of AMD by about 25% and visual acuity loss by 19 % in individuals at high risk for the disease.

• #1 Age-Related Macular Degeneration

  https://www.asrs.org/patients/retinal-diseases/2/agerelated-macular-degeneration

  Anti-VEGF drugs have greatly improved wet-AMD treatment since 2005; patients today have a much better chance of maintaining their central vision so they can read, drive, recognize faces, and live normal lives. […] There are currently two possible treatments, Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) for GA (the advanced form of dry AMD) which can slow progression of vision loss in some eyes. These are also injections in the eye which are given every one to two months. […] The Age-Related Eye Disease Studies (AREDS), conducted by the National Eye Institute, have found that a nutritional supplement formula may delay and prevent intermediate dry AMD from moving to the advanced form. […] The AREDS supplement formula, which is widely available over the counter, contains: Vitamin C, Lutein, Vitamin E, Zeaxanthin, Zinc.

• #1

  https://www.aao.org/eye-health/diseases/amd-macular-degeneration

  Age-Related Macular Degeneration Treatment […] Right now, only dry AMD with geographic atrophy can be treated. Two new medications are available: pegcetacoplan and avacincaptad pegol. One of these will be injected into your eye to slow the atrophy. Hopefully, this will delay vision loss. […] There is no treatment for drusen. However people with lots of drusen or serious vision loss might benefit from taking a certain combination of nutritional supplements. A large study (AREDS and the later AREDS 2 study) found people with certain drusen may slow their dry AMD by taking these vitamins and minerals daily: Vitamin C (500 mg), Vitamin E (400 IU), Lutein (10 mg), Zeaxanthin (2 mg), Zinc (80 mg), Copper (2 mg). […] Your ophthalmologist can tell you if vitamins and minerals are recommended for your dry AMD, as not all forms will benefit from the AREDS supplements. Beta carotene should not be used by smokers as it raised the risk of lung cancer. […] To help treat wet AMD, there are medications called anti-VEGF drugs. Anti-VEGF treatment helps reduce the number of abnormal blood vessels in your retina. It also slows any leaking from blood vessels. This medicine is delivered to your eye through a very slender needle. […] Laser surgery may also be used to treat some types of wet AMD. Your eye surgeon shines a laser light beam on the abnormal blood vessels. This reduces the number of vessels and slows their leaking. […] Talk with your ophthalmologist about ways to treat your AMD.

• #1 Dry macular degeneration – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/dry-macular-degeneration/diagnosis-treatment/drc-20350381

  These steps will help tell you if your condition develops into wet macular degeneration, which can be treated with medicines. […] Will taking a vitamin or mineral supplement help prevent further vision loss? […] What low vision aids might be helpful to me? […] What lifestyle changes can I make to protect my vision?

• #1

• #1 Nonexudative (Dry) Age-Related Macular Degeneration (AMD) Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1223154-treatment

  Intravitreal complement inhibitors have been approved by the FDA for treatment of geographic atrophy (GA). Complement is thought to play a key role in retinal degeneration secondary to AMD. Pegcetacoplan intravitreal (Syfovre) and avacincaptad pegol intravitreal (Izervay) are complement inhibitors that inhibit cleavage of C5, preventing its cleavage to C5a and C5b and thus decreasing membrane attack complex (MAC) formation that results in cell death. […] Pegcetacoplan intravitreals approval for GA was supported by results from the phase 3 OAKS (n = 637) and DERBY (n = 621) studies. At 24 months, the treatment effects of pegcetacoplan were similar between the trials. Reductions in GA lesion growth from baseline were approximately 16-18% with every other month dosing and 19-22% with monthly dose of pegcetacoplan compared with placebo (P 0.003 or less).

• #1 What is the Latest Treatment for Dry Macular? | Eye Center of Texas

  https://www.eyecenteroftexas.com/2023/12/what-is-latest-treatment-for-dry-macular/

  At the end of 2023, the FDA approved yet another new treatment for macular degeneration known as IZERVAY, formerly Zimura. […] The active ingredient in IZERVAY is called Avacincaptad Pegol, which selectively blocks a protein called C5 that has been found to cause retinal cell damage in dry AMD. […] IZERVAY is administered as an intraocular injection, given once every three months. […] Izervays effectiveness was demonstrated in rigorous clinical trials involving over 700 patients. […] In addition to its primary benefits, Izervay has also been reported to be well tolerated by most patients. […] In 2023, the FDA approved two new drug options for patients suffering from the symptoms of dry AMD: Pegcetacoplan (Syfovre) and Avacincaptad Pegol (IZERVAY). […] The introduction of these drugs into the market represents a significant step forward in the field of ophthalmology and the fight against AMD.

• #1 Age related macular degeneration (AMD) – Progressive Vision

  https://www.progressivevision.ie/age-related-macular-degeneration/

  Clinical trials have shown benefits in visual function following treatment 3 times a week for 3-4 weeks. […] The treatment for wet AMD is injections of an anti-vascular endothelial growth factor (anti-VEGF) medicine into the eye. […] The treatment consists of a loading dose of 3 injections 4 weeks apart and then an assessment to see if the wet AMD has responded. […] Laser surgery is sometimes used to treat some types of wet AMD. […] REMEMBER AMD will not cause a total loss of vision. If you have AMD, help and support is available to maximise your remaining vision and to help you maintain an active and independent life. Early detection is important.

• #1 Age-Related Macular Degeneration

  https://www.asrs.org/patients/retinal-diseases/2/agerelated-macular-degeneration

  Wet-AMD treatment has been revolutionized in recent years after the discovery of vascular endothelial growth factor (VEGF), a family of compounds in the body. VEGF regulates the growth of abnormal new blood vessels in the eye known as neovascularization that can lead to wet AMD. […] Anti-VEGF drugs have been developed to help stop neovascularization and preserve vision for AMD patients. There are currently 5 different anti-VEGF drugs: Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), Beovu (brolucizumab), Vabysmo (faricimab). […] Wet AMD cannot be cured, but its progression may be blocked with the use of intravitreal (in-the-eye) anti-VEGF injections. These injections may preserve, and even recover, vision. Local anesthetic eye drops are given before the injections to numb the eye and minimize discomfort.

• #1 Macular disease treatments – Macular Society

  https://www.macularsociety.org/diagnosis-treatment/treatments/

  Dry aged-related macular degeneration (AMD) is a slow deterioration of the cells of the macula, often over many years. There is no medical treatment for dry AMD but research is going on around the world, including research funded by the Macular Society. […] There are now treatments for wet AMD which slow the progress of the condition in most people. Treatment has to be given quickly, before there is permanent scarring to the macula. […] Clinical Guideline recommends that people with suspected wet AMD should be referred to a retinal specialist immediately. If treatment is needed, it should be given within 14 days of the initial referral. […] Several drugs are used to treat wet AMD. They are known as anti-VEGF drugs. […] In wet AMD, too much VEGF is produced in the eye, causing the growth of unwanted, unhealthy blood vessels. Anti-VEGF drugs block the production of VEGF and stop the development of abnormal blood vessels.

• #1 Treatments for Wet AMD (Advanced Neovascular AMD) | National Eye Institute

  https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration/treatments-wet-amd-advanced-neovascular-amd

  Age-related macular degeneration (AMD) is an eye disease that can blur the center of your vision. Wet AMD (also called advanced neovascular AMD) is a serious type of late AMD. The good news is that there are effective treatments for wet AMD. There are 2 treatment options that can slow down or stop vision loss from wet AMD: Anti-VEGF injections and Photodynamic therapy (PDT). If you have vision loss from wet AMD, ask your eye doctor if either of these treatments could help you. The most common treatment doctors use to slow vision loss from wet AMD is called anti-VEGF injections. These medicines help stop bleeding and leaking from blood vessels in the back of your eye. Most people with wet AMD will get anti-VEGF injections as their only treatment. Anti-VEGF injections usually only work for a short time, so most people need to get them many times. At first, most people need injections once a month. After that, your doctor will tell you how often you need injections to help stop vision loss from AMD. Photodynamic therapy (PDT) is a much less common treatment for wet AMD that doctors sometimes use along with anti-VEGF injections. Some people will need to get PDT more than once. Talk to your doctor to find out if you will need more treatments to help stop vision loss from AMD.

• #1 Age-Related Macular Degeneration Treatment and Therapies – Eye & Ear Foundation of Pittsburgh

  https://eyeandear.org/2022/11/age-related-macular-degeneration-treatment-and-therapies/

  APL-2 C3 Inhibition (Apellis) […] Monthly or every other month intravitreal injections […] Phase III trials […] Reduction in geographic atrophy (GA) growth by 22%/16%. […] Zimura C5 Inhibition (IvericBio) […] Monthly intravitreal injections, 2 mg or 4 mg […] Phase III trials […] Reduction in GA growth by 27.4%/27.8%. […] Anti-Vascular Endothelial Growth Factor Intravitreal Injections […] Bevacizumab (Avastin) […] First used in 2004 […] Ranibizumab (Lucentis) […] Approved in 2006 […] Aflibercept (Eylea) […] Approved in 2012 […] Brolucizumab (Beovu) […] Approved in 2020 […] Faricimab (Vabysmo) […] Approved in 2022. […] New therapies are under development that affect metabolism: […] Drugs (Metformin, 8-OH-DPAT) […] Proteins (LIF, OSM) […] Gene Therapies (LIF, STAT3, PGC-1a).

• #1 Macular disease treatments – Macular Society

  https://www.macularsociety.org/diagnosis-treatment/treatments/

  All anti-VEGF drugs need to be delivered directly into the eye. […] The current method is injections, however new methods are being delivered. […] In accordance with NICE AMD guidelines, all patients receive a standard loading dosage at the start of their injection treatment: normally three or more consecutive monthly injections. […] After this initial phase there are a number of treatment regimens that an ophthalmologist can choose. […] There are a few different medications used to treat wet AMD. They all are effective in treating the eye. […] Avastin (bevacizumab) may be used in some circumstances. […] Lucentis (ranibizumab) was the first anti-VEGF to be licensed for wet AMD. […] Eylea (aflibercept) is longer lasting in the eye compared to Lucentis, on average a patient may only need to attend treatment every eight weeks.

• #1 Age-Related Macular Degeneration (AMD) Care in Houston & San Antonio, TX

  https://www.retinaconsultantstexas.com/treatment/retina-conditions/macular-degeneration

  Fortunately, medications now available can benefit over 90% of wet AMD patients. […] Repeated injections of anti-VEGF agents (Avastin, Lucentis Eylea) have been firmly established as the optimal treatment for wet AMD. […] These powerful drugs are given as injections into the eye to suppress abnormal blood vessel growth and leakage. […] New research is constantly being conducted to find new and improved ways of inhibiting neovascularization using anti-VEGF therapies, paving the way for potential future treatments for wet AMD. […] At Retina Consultants of Texas, preserving your vision is our mission. We offer a full spectrum of retinal care using the most advanced technologies to address diseases of the retina, macula, and vitreous. For world-class retinal care, including age-related macular degeneration treatment, schedule an appointment with RCTX in the Greater Houston and Greater San Antonio, TX areas today.

• #1 AMD Disease | Age Related Macular Degeneration Treatment FAQ’s & Info

  https://www.retinadoctor.com.au/conditions/age-related-macular-degeneration-amd/

  Age-related macular degeneration (also known as AMD) is the most common cause of blindness in people over the age of 50 in Australia as well as in most modern societies. […] Urgent wet age related macular degeneration treatment can prevent further visual loss and even improve vision significantly. […] Unfortunately, there is no dry age related macular degeneration treatment available at the moment, but there are clinical trials that have reported encouraging interim results. […] While there is no cure for wet or dry macular degeneration, a treatment does exist for wet AMD that can help to slow the progression of the disease. […] Until mid-2006, the two main treatments available for wet AMD disease were laser and photodynamic therapy (PDT). […] Fortunately, it is now possible to prevent worsening of vision in nearly 95% of patients and improve vision significantly in up to 40% with repeated intravitreal injections of drugs. […] As a result, many patients now have treatment on a one- to three-monthly basis. At present, until alternatives become available, this is probably a lifelong ongoing treatment.

• #1 Wet macular degeneration – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/wet-macular-degeneration/diagnosis-treatment/drc-20351113

  Possible risks of these shots include: Conjunctival hemorrhage, Increased eye pressure, Infection, Retinal detachment, Eye inflammation. […] Photodynamic therapy. This procedure is a possible treatment for the irregular blood vessel growth in wet macular degeneration. However, it is much less common than treatment with anti-VEGF shots. […] During photodynamic therapy, an eye doctor injects a medicine called verteporfin (Visudyne) into a vein in the arm. The medicine then travels to blood vessels in the eye. An eye doctor shines a focused light from a special laser on the affected blood vessels in the eye. This activates the verteporfin, causing the blood vessels to close. This stops the leakage. […] Photodynamic therapy may improve vision and reduce the rate of vision loss. Repeated treatments may be needed over time, as the treated blood vessels may reopen.

• #1 Age-Related Macular Degeneration Treatment

  https://www.webmd.com/eye-health/macular-degeneration/age-related-macular-degeneration-treatment

  Photodynamic therapy. It’s a two-step treatment for wet AMD that uses a light-sensitive drug to damage your abnormal blood vessels. […] Laser therapy. Your doctor may suggest a treatment with high-energy laser light that can seal and sometimes destroy actively growing abnormal blood vessels from wet AMD. […] The right treatment not only slows your vision loss, but it can improve your vision.

• #1 Diagnosis and Treatment – Moorfields Private

  https://www.moorfields.nhs.uk/private/eye-conditions-and-treatments/age-related-macular-degeneration-amd/diagnosis-and-treatment

  Age-related macular degeneration (AMD) is diagnosed by eye care specialists called optometrists. […] If AMD is suspected, you may be referred to an eye doctor (ophthalmologist) or specialist AMD service. […] Regular comprehensive eye exams, even without vision changes, are advised to detect early AMD before major vision loss occurs. Early detection and timely treatment are key to preserving sight threatened by AMD progression. […] Unfortunately, there are currently no dry macular degeneration treatment options available. […] Wet AMD is treated with anti-VEGF (vascular endothelial growth factor) injections into the eye. […] Photodynamic therapy (PDT) is sometimes added to anti-VEGF injections. […] Anti-VEGF drugs like ranibizumab (Lucentis) and bevacizumab (Avastin) are injected into the eye to treat conditions where abnormal blood vessels leak fluid under the retina at the back of the eye.

• #1 AMD (Age-Related Macular Degeneration) – Prevent Blindness

  https://preventblindness.org/amd-age-related-macular-degeneration/

  Anti-vascular endothelial growth factor (anti-VEGF) drugs and bispecific monoclonal antibody drugs: The current standard treatment, these drugs block the development of new blood vessels and limit the leakage from the abnormal blood vessels in the eye. They are delivered through an injection or implant into the eye, administered by an ophthalmologist, usually a retinal specialist. While some pressure will be felt during the injection, the eye is first numbed to minimize any discomfort. Several injections over time are needed in this treatment (frequency of injections varied based on the drug selected and the eye doctors judgment). […] Photodynamic therapy (PDT): Only used occasionally, PDT uses a laser beam with a light-sensitive dye to destroy unhealthy new blood vessels in or under the retina. Multiple treatments may be needed, as directed by the eye doctor.

• #1 Age-Related Macular Degeneration Research Advances — Foundation Fighting Blindness

  https://www.fightingblindness.org/news/age-related-macular-degeneration-research-advances-821

  Genentechs Susvimo, a permanent, refillable implant the size of a rice grain, provides continual delivery of an anti-VEGF treatment to the retina. […] Genentech, a global biotechnology company and member of the Roche Group, has shown that VabysmoTM (faricimab-svoa) is effective for for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). […] Regenerons wet AMD treatment, Eylea, blocks the development of unhealthy blood vessels that lead to vision loss. […] REGENXBIO, a clinical-stage gene therapy biotechnology company, is conducting two pivotal, Phase 3 clinical trials for RGX-314, its gene therapy designed to halt the growth of leaky blood vessels that cause retinal degeneration and central vision loss in people with the wet form of age-related macular degeneration (AMD).

• #1

  https://www.aao.org/eye-health/tips-prevention/promising-new-treatments-amd

  The goal of gene therapy is to provide a one-and-done treatment by helping the eye make its own anti-VEGF medicine. […] For people with intermediate disease, a formulation of antioxidant vitamins called the AREDS2 formula can help reduce the risk of vision loss. […] Today, two new therapies are accessible for patients with GA. […] Two new drugs that target the complement cascade and stop it from attacking the retina have recently been approved by the FDA: Pegcetacoplan (SYFOVRE) and avacincaptad pegol (Izervay). […] Another concept under investigation is the possibility of replacing some cells that begin to die in late-stage dry AMD. […] Stem cells may be able to replace the retinal cells that are killed off by this disease.

• #1 Age-related macular degeneration (AMD): Symptoms, treatment

  https://www.medicalnewstoday.com/articles/152105

  In 2022, the National Institutes of Health reported that the first person in the United States had received autologous stem cell therapy to treat dry AMD. […] IMT treatment might improve the vision of people with advanced AMD. It involves implanting a small device to help a person recover some vision and have more independence. […] A 2020 review suggests that some herbal and natural remedies may help prevent AMD, although there is not enough evidence to show that they will make a difference. […] For a person with AMD in one eye, dietary supplements may help prevent or slow the development of AMD in the other eye. […] AREDS 2 supplements consist of a special formulation for people who have or are at risk of AMD.

• #1

  https://www.aao.org/eye-health/tips-prevention/promising-new-treatments-amd

  „Today, more durable therapies are coming out, and treatments that may even cure the disease are in the works. Theres a lot of hope for people with AMD,” Sridhar says. […] Some of the most exciting research today explores alternatives to frequent injections. […] A new, higher-dose version of well-established anti-VEGF medicine Eylea may allow patients to go longer in between injections. […] Another new drug that targets two underlying causes of AMD has been FDA approved for both AMD and diabetic macular edema. […] Faricimab (Vabysmo), targets both VEGF and the protein angiopoietin-2. […] It may also be possible to combine two drugs and hit wet AMD with a double punch. […] Gene therapy is a promising alternative to ongoing eye injections of drugs such as Eylea, Lucentis, Vabysmo and Avastin.

• #1 Macular disease treatments – Macular Society

  https://www.macularsociety.org/diagnosis-treatment/treatments/

  The second is if the blood vessels that are causing the damage have been successfully suppressed and they are no longer leaking onto the macula. […] On rare occasions some people may be offered laser treatment. […] Researchers all over the world are working hard to find new and improved treatments for AMD. […] One area that is being highly researched is the development of longer acting drugs for wet AMD. […] Another way of reducing injections is an implant containing a drug reservoir. […] Research is also underway with the aim of moving away from the need for eye injections completely, but it is still in very early stages. […] Among the options being explored are treatments to reduce the inflammation thought to lead to dry AMD. […] Another promising approach is stem cell therapy. […] Clinical trials of stem cell therapies are underway for both wet and dry AMD.

• #1 Age-Related Macular Degeneration Treatment and Therapies – Eye & Ear Foundation of Pittsburgh

  https://eyeandear.org/2022/11/age-related-macular-degeneration-treatment-and-therapies/

  This disease has a large patient population size. […] Over 10 million patients in USA […] Affects 1 in 8 people 60 years of age or older […] Most common cause of irreversible blindness in older persons in developed countries […] 200 million people worldwide […] Projected 288 million people by 2040. […] These were very large studies with strong scientific proof that these vitamins really are effective, but unfortunately the efficacy was not as robust as hoped, and the results from AREDS2 were not superior to the original formula, Dr. Anetakis said. They do slow the disease, and they are still worth taking. […] There is ongoing innovation in the retina pipeline, with research, clinical trials, and different ways different companies are attacking this problem. The most common or robust is looking at inflammation ways of modulating it.

• #1 Age-Related Macular Degeneration (AMD)

  https://www.healthline.com/health/macular-degeneration

  Theres currently no cure available for macular degeneration, but your doctor can recommend options to help slow the progression. […] If you have vision loss from either dry or wet macular degeneration, you may benefit from working with a low-vision rehabilitation specialist. The specialist can teach you how to adjust to and cope with vision loss. […] In terms of treatment, you have the following options: […] Your doctor may also inject a medication directly into your eye to stop the growth of new blood vessels. […] These medications are known as anti-vascular endothelial growth factor (anti-VEGF) drugs. They include ranibizumab (Lucentis) and aflibercept (Eylea). It can take several weeks of treatment before you notice a difference. […] In addition, two new medications have been approved recently by the FDA to treat dry macular degeneration: avacincaptad pegol (Izervay) and pegcetacoplan (Syfovre).

• #1 Age-Related Macular Degeneration (AMD): Causes, Symptoms and Treatments

  https://www.allaboutvision.com/conditions/macular-degeneration/age-related/

  The implantable miniature telescope (IMT) is an additional treatment option for some patients with end-stage AMD. Surgically placed in the eye, this device helps improve a person’s vision by enlarging the images they see. […] Other methods of treating wet and dry macular degeneration are currently under investigation. […] For AMD patients who have suffered any degree of vision loss, low vision devices such as magnifiers, telescopes and apps on digital devices can help maximize their vision potential. Large-print products may also be available for further accessibility. Low vision aids contribute to quality-of-life improvements for people with long-term vision loss.

• #1

  https://northbayeye.com/community-content/types-of-age-related-macular-degeneration-and-treatments

  If you have the wet form of AMD, your eye doctor may recommend injectable medications that prevent abnormal blood vessels from growing in your eye. The injections use very small needles and can be placed in the corner of your eye. […] No matter what type of AMD you have, you may benefit from magnifiers, eyeglasses with telescopic lenses, large print books, software programs that convert text to speech, and other low vision aids.

• #1 Eyes – age-related macular degeneration | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/age-related-macular-degeneration

  Age-related macular degeneration (AMD) is a type of vision loss characterised by the distortion or absence of the central field of vision. […] There is no cure for AMD but treatment aims to preserve vision for as long as possible. […] Treatment includes occupational therapy to help the person adapt to vision loss. […] Currently, there is no effective treatment available to reverse the effects of the dry form of AMD. However, you should discuss diet, supplements and lifestyle options with your health professional. […] Options to treat the wet form of AMD include: Injections the wet form of AMD may be treated with an injection of a drug directly into the eye. The drug helps to stop the abnormal growth of blood vessels. The majority of people treated are able to maintain their vision and some peoples vision may even improve. This is done as an outpatient procedure so you dont need to stay in hospital overnight.

• #1 Treatments for Age-Related Macular Degeneration

  https://www.retinaspecialistsmd.com/what-we-treat/age-related-macular-degeneration/

  A class of drugs known as anti-VEGF is the most recent and most commonly utilized treatment for the complication of AMD known as wet AMD. […] This treatment option was one of the first in the wave of new therapies in the advancement of treatments for the abnormal blood vessels that grow under the macula in wet AMD. […] Until the availability of the therapy options above focal laser was the standard of treatment for wet AMD. […] As good as these treatments are, they are only temporary and close follow-up and often retreatment is necessary. […] Various sophisticated and complex forms of intraocular surgery are available for advanced complicated forms of hemorrhaging wet AMD. […] For those who have advanced stages of AMD with vision loss; there is an array of optical devices and visual aids available. […] Amsler grid testing is a very sensitive method of detecting early changes in your central vision.

• #1 Macular Degeneration AMD | Retina Group of Washington | Wet & Dry AMD MD VA DC

  https://www.rgw.com/age-related-macular-degeneration-amd/

  Age Related Macular Degeneration (AMD) is the leading cause of vision loss for people over 60 years of age. AMD gradually destroys the central vision needed to see objects clearly and to perform common daily tasks. […] If Macular Degeneration is diagnosed early enough, we are very fortunate to have a number of possible treatment options that may help to slow or even halt the progression of vision loss. However, patients must understand that once the macula has been damaged, there is no treatment that currently can reverse that damage and the associated loss of vision. […] Avastin®, Eylea® and Lucentis® Injections are intravitreal injections-that means an injection that is placed directly into the Vitreous of the eye. Generally they need to be repeated every four to six weeks. Clinical studies of these anti-VEGF Injections indicate that when given to patients who have evidence of new blood vessel formation monthly, over 90% of patients will maintain their vision.

• #1 Treatment for Age-Related Macular Degeneration | Macular Disease Foundation Australia

  https://www.mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-treatment/

  Anti-VEGF eye injections can save the sight of people with wet AMD. […] There is no cure for age-related macular degeneration (AMD). However, there is effective, sight-saving treatment for the most aggressive form of the disease: wet (neovascular) age-related macular degeneration. […] There is highly effective treatment for wet (neovascular) AMD. This is most commonly delivered in the form of regular injections to the eye. […] Anti-VEGF medication can block the activity of this VEGF protein, thereby stopping the growth of abnormal blood vessels and fluid leakage. […] Standard treatment for wet AMD involves an injection of anti-VEGF medication into the clear, jelly-like substance (called the vitreous) inside the eye. […] Eye injections are also called intravitreal injections or IVI.

• #1 Treatment for Age-Related Macular Degeneration | Macular Disease Foundation Australia

  https://www.mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-treatment/

  For most people, treatment usually begins with injections at monthly intervals. Your injection schedule will depend on how you respond to the treatment. Your ophthalmologist may extend the time between treatment. But, typically, you’ll receive injections every four to 12 weeks. […] Laser photocoagulation and photodynamic therapy (PDT) are now rarely used to treat wet (neovascular) AMD. […] In some people, treatment can improve vision. However, these treatments don’t cure the disease. […] Currently, there are no medical treatments for early or intermediate AMD. However, researchers are trying to develop treatments that stop or slow progression to late AMD. […] Currently there are no medical treatments available for dry (atrophic) AMD, however research is ongoing to develop treatments.

• #2

  https://www.nhs.uk/conditions/age-related-macular-degeneration-amd/treatment/

  There is no cure for age-related macular degeneration (AMD), but there are treatments and support available to help slow down the changes in your vision and help you have the best quality of life. […] The type of treatment depends on the stage and the type of late-stage AMD you have: dry AMD or wet AMD. […] Treatments for wet AMD include: injections of medicine (anti-VEGF) given directly into the eyes […] light treatment to destroy the blood vessels that cause wet AMD. […] There’s currently no treatment for dry AMD, but support is available to help you live with AMD, including help with low vision and lifestyle changes. […] Research into possible new treatments for AMD is ongoing.

• #2 Treatment for Age-Related Macular Degeneration | Macular Disease Foundation Australia

  https://www.mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-treatment/

  For most people, treatment usually begins with injections at monthly intervals. Your injection schedule will depend on how you respond to the treatment. Your ophthalmologist may extend the time between treatment. But, typically, you’ll receive injections every four to 12 weeks. […] Laser photocoagulation and photodynamic therapy (PDT) are now rarely used to treat wet (neovascular) AMD. […] In some people, treatment can improve vision. However, these treatments don’t cure the disease. […] Currently, there are no medical treatments for early or intermediate AMD. However, researchers are trying to develop treatments that stop or slow progression to late AMD. […] Currently there are no medical treatments available for dry (atrophic) AMD, however research is ongoing to develop treatments.

• #2 Age-related Macular Degeneration: Causes and Treatment

  https://www.aarp.org/health/conditions-treatments/early-signs-of-macular-degeneration/

  An essential part of any treatment plan no matter the stage or form of AMD is a healthy lifestyle, including regular exercise and a diet that incorporates plenty of fish and leafy green vegetables. Research published in American Journal of Ophthalmology suggests exercise helps guard against AMD. […] And a review of studies published in 2021 in the journal Clinical Nutrition showed that regularly eating fish, especially fatty fish like salmon, tuna, sardines, mackerel and herring which are high in omega-3 fatty acids, can reduce your risk of developing AMD. […] Although there’s no cure for macular degeneration, there are things you can do to slow its progression. […] Research, including a recent review of studies published in the journal Ophthalmology, shows that taking high-dose vitamins and minerals specifically, vitamins C and E, zinc, lutein, zeaxanthin, beta-carotene and copper slows progression of the disease in people with intermediate AMD and those with late-stage dry AMD.

• #2 Age-Related Macular Degeneration

  https://www.asrs.org/patients/retinal-diseases/2/agerelated-macular-degeneration

  Anti-VEGF drugs have greatly improved wet-AMD treatment since 2005; patients today have a much better chance of maintaining their central vision so they can read, drive, recognize faces, and live normal lives. […] There are currently two possible treatments, Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) for GA (the advanced form of dry AMD) which can slow progression of vision loss in some eyes. These are also injections in the eye which are given every one to two months. […] The Age-Related Eye Disease Studies (AREDS), conducted by the National Eye Institute, have found that a nutritional supplement formula may delay and prevent intermediate dry AMD from moving to the advanced form. […] The AREDS supplement formula, which is widely available over the counter, contains: Vitamin C, Lutein, Vitamin E, Zeaxanthin, Zinc.

• #2 Age-Related Macular Degeneration

  https://www.asrs.org/patients/age-related-macular-degeneration

  Wet AMD cannot be cured, but its progression may be stopped with intravitreal (in-the-eye) anti-VEGF injections. […] Anti-VEGF drugs can preserve vision for AMD patients. That means if you have wet AMD you have a much better chance of maintaining your central vision so you can read, drive, recognize faces, and live a normal life. […] No treatment can prevent visual loss for patients with the advanced form of dry AMD. However, the Age-Related Eye Disease Studies (AREDS), conducted by the National Eye Institute, found that a nutritional supplement formula may delay and prevent intermediate dry AMD from moving to the advanced form. […] If you have advanced dry AMD, you may want to take an AREDS-2 supplement formula, which is widely available over the counter, containing: Vitamin C, Lutein, Vitamin E, Zeaxanthin, Zinc.

• #2

  https://www.aao.org/eye-health/diseases/amd-macular-degeneration

  Age-Related Macular Degeneration Treatment […] Right now, only dry AMD with geographic atrophy can be treated. Two new medications are available: pegcetacoplan and avacincaptad pegol. One of these will be injected into your eye to slow the atrophy. Hopefully, this will delay vision loss. […] There is no treatment for drusen. However people with lots of drusen or serious vision loss might benefit from taking a certain combination of nutritional supplements. A large study (AREDS and the later AREDS 2 study) found people with certain drusen may slow their dry AMD by taking these vitamins and minerals daily: Vitamin C (500 mg), Vitamin E (400 IU), Lutein (10 mg), Zeaxanthin (2 mg), Zinc (80 mg), Copper (2 mg). […] Your ophthalmologist can tell you if vitamins and minerals are recommended for your dry AMD, as not all forms will benefit from the AREDS supplements. Beta carotene should not be used by smokers as it raised the risk of lung cancer. […] To help treat wet AMD, there are medications called anti-VEGF drugs. Anti-VEGF treatment helps reduce the number of abnormal blood vessels in your retina. It also slows any leaking from blood vessels. This medicine is delivered to your eye through a very slender needle. […] Laser surgery may also be used to treat some types of wet AMD. Your eye surgeon shines a laser light beam on the abnormal blood vessels. This reduces the number of vessels and slows their leaking. […] Talk with your ophthalmologist about ways to treat your AMD.

• #2 Age-Related Macular Degeneration (AMD)

  https://www.healthline.com/health/macular-degeneration

  Theres currently no cure available for macular degeneration, but your doctor can recommend options to help slow the progression. […] If you have vision loss from either dry or wet macular degeneration, you may benefit from working with a low-vision rehabilitation specialist. The specialist can teach you how to adjust to and cope with vision loss. […] In terms of treatment, you have the following options: […] Your doctor may also inject a medication directly into your eye to stop the growth of new blood vessels. […] These medications are known as anti-vascular endothelial growth factor (anti-VEGF) drugs. They include ranibizumab (Lucentis) and aflibercept (Eylea). It can take several weeks of treatment before you notice a difference. […] In addition, two new medications have been approved recently by the FDA to treat dry macular degeneration: avacincaptad pegol (Izervay) and pegcetacoplan (Syfovre).

• #2 What is the Latest Treatment for Dry Macular? | Eye Center of Texas

  https://www.eyecenteroftexas.com/2023/12/what-is-latest-treatment-for-dry-macular/

  These were some of the only treatment options until the end of 2023. As we mentioned above, groundbreaking research has led to the approval of several new drugs for macular degeneration treatment, offering patients more options than ever before. […] Syfovre, a product of Apellis Pharmaceuticals, represents a significant breakthrough in the management of dry AMD, with its active ingredient Pegcetacoplan designed to halt the diseases progression. […] This innovative treatment, administered through intraocular injection either monthly or bimonthly, has proven its efficacy in the treatment of geographic atrophy, a catastrophic outcome of age-related macular degeneration. […] The safety and effectiveness of Syfovre were confirmed in two Phase III clinical trials. […] The investigations reveal that the effectiveness of Pegcetacoplan increases over time. It not only decelerates the disease but also helps prevent further retinal degeneration.

• #2 What is the Latest Treatment for Dry Macular? | Eye Center of Texas

  https://www.eyecenteroftexas.com/2023/12/what-is-latest-treatment-for-dry-macular/

  At the end of 2023, the FDA approved yet another new treatment for macular degeneration known as IZERVAY, formerly Zimura. […] The active ingredient in IZERVAY is called Avacincaptad Pegol, which selectively blocks a protein called C5 that has been found to cause retinal cell damage in dry AMD. […] IZERVAY is administered as an intraocular injection, given once every three months. […] Izervays effectiveness was demonstrated in rigorous clinical trials involving over 700 patients. […] In addition to its primary benefits, Izervay has also been reported to be well tolerated by most patients. […] In 2023, the FDA approved two new drug options for patients suffering from the symptoms of dry AMD: Pegcetacoplan (Syfovre) and Avacincaptad Pegol (IZERVAY). […] The introduction of these drugs into the market represents a significant step forward in the field of ophthalmology and the fight against AMD.

• #2 Age-Related Macular Degeneration Treatment and Therapies – Eye & Ear Foundation of Pittsburgh

  https://eyeandear.org/2022/11/age-related-macular-degeneration-treatment-and-therapies/

  APL-2 C3 Inhibition (Apellis) […] Monthly or every other month intravitreal injections […] Phase III trials […] Reduction in geographic atrophy (GA) growth by 22%/16%. […] Zimura C5 Inhibition (IvericBio) […] Monthly intravitreal injections, 2 mg or 4 mg […] Phase III trials […] Reduction in GA growth by 27.4%/27.8%. […] Anti-Vascular Endothelial Growth Factor Intravitreal Injections […] Bevacizumab (Avastin) […] First used in 2004 […] Ranibizumab (Lucentis) […] Approved in 2006 […] Aflibercept (Eylea) […] Approved in 2012 […] Brolucizumab (Beovu) […] Approved in 2020 […] Faricimab (Vabysmo) […] Approved in 2022. […] New therapies are under development that affect metabolism: […] Drugs (Metformin, 8-OH-DPAT) […] Proteins (LIF, OSM) […] Gene Therapies (LIF, STAT3, PGC-1a).

• #2 Nonexudative (Dry) Age-Related Macular Degeneration (AMD) Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1223154-treatment

  Intravitreal complement inhibitors have been approved by the FDA for treatment of geographic atrophy (GA). Complement is thought to play a key role in retinal degeneration secondary to AMD. Pegcetacoplan intravitreal (Syfovre) and avacincaptad pegol intravitreal (Izervay) are complement inhibitors that inhibit cleavage of C5, preventing its cleavage to C5a and C5b and thus decreasing membrane attack complex (MAC) formation that results in cell death. […] Pegcetacoplan intravitreals approval for GA was supported by results from the phase 3 OAKS (n = 637) and DERBY (n = 621) studies. At 24 months, the treatment effects of pegcetacoplan were similar between the trials. Reductions in GA lesion growth from baseline were approximately 16-18% with every other month dosing and 19-22% with monthly dose of pegcetacoplan compared with placebo (P 0.003 or less).

• #2 Age related macular degeneration (AMD) – Progressive Vision

  https://www.progressivevision.ie/age-related-macular-degeneration/

  Age-Related Macular Degeneration (AMD) is the number one cause of sight loss in Ireland for those aged over 50. More than 100,000 people in Ireland aged over 50 are living with AMD. The earlier AMD is detected, the sooner it can be treated to reduce its progression. […] Taking oral carotenoid supplements containing lutein (10mg), zeaxanthin (2mg) and meso-zeaxanthin (10mg) can slow down the progression of dry AMD by increasing the macular pigment levels. […] Progressive Vision is proud to be Irelands first eye clinic to offer a new treatment for DRY AMD (age-related macular degeneration). […] The Valeda Light Delivery System (LDS) is the ONLY available treatment for Dry AMD using a safe, non-invasive and painless therapy photobiomodulation. […] Studies have shown that Valeda photobiomodulation therapy can improve visual outcomes.

• #2 Treatment for Age-Related Macular Degeneration | Macular Disease Foundation Australia

  https://www.mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-treatment/

  Anti-VEGF eye injections can save the sight of people with wet AMD. […] There is no cure for age-related macular degeneration (AMD). However, there is effective, sight-saving treatment for the most aggressive form of the disease: wet (neovascular) age-related macular degeneration. […] There is highly effective treatment for wet (neovascular) AMD. This is most commonly delivered in the form of regular injections to the eye. […] Anti-VEGF medication can block the activity of this VEGF protein, thereby stopping the growth of abnormal blood vessels and fluid leakage. […] Standard treatment for wet AMD involves an injection of anti-VEGF medication into the clear, jelly-like substance (called the vitreous) inside the eye. […] Eye injections are also called intravitreal injections or IVI.

• #2 Treatments for Wet AMD (Advanced Neovascular AMD) | National Eye Institute

  https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration/treatments-wet-amd-advanced-neovascular-amd

  Age-related macular degeneration (AMD) is an eye disease that can blur the center of your vision. Wet AMD (also called advanced neovascular AMD) is a serious type of late AMD. The good news is that there are effective treatments for wet AMD. There are 2 treatment options that can slow down or stop vision loss from wet AMD: Anti-VEGF injections and Photodynamic therapy (PDT). If you have vision loss from wet AMD, ask your eye doctor if either of these treatments could help you. The most common treatment doctors use to slow vision loss from wet AMD is called anti-VEGF injections. These medicines help stop bleeding and leaking from blood vessels in the back of your eye. Most people with wet AMD will get anti-VEGF injections as their only treatment. Anti-VEGF injections usually only work for a short time, so most people need to get them many times. At first, most people need injections once a month. After that, your doctor will tell you how often you need injections to help stop vision loss from AMD. Photodynamic therapy (PDT) is a much less common treatment for wet AMD that doctors sometimes use along with anti-VEGF injections. Some people will need to get PDT more than once. Talk to your doctor to find out if you will need more treatments to help stop vision loss from AMD.

• #2 Age-Related Macular Degeneration

  https://www.asrs.org/patients/retinal-diseases/2/agerelated-macular-degeneration

  Wet-AMD treatment has been revolutionized in recent years after the discovery of vascular endothelial growth factor (VEGF), a family of compounds in the body. VEGF regulates the growth of abnormal new blood vessels in the eye known as neovascularization that can lead to wet AMD. […] Anti-VEGF drugs have been developed to help stop neovascularization and preserve vision for AMD patients. There are currently 5 different anti-VEGF drugs: Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), Beovu (brolucizumab), Vabysmo (faricimab). […] Wet AMD cannot be cured, but its progression may be blocked with the use of intravitreal (in-the-eye) anti-VEGF injections. These injections may preserve, and even recover, vision. Local anesthetic eye drops are given before the injections to numb the eye and minimize discomfort.

• #2 Photodynamic Therapy for Age-Related Macular Degeneration Information

  https://www.columbiadoctors.org/health-library/article/photodynamic-therapy-age-related-macular-degeneration/

  Photodynamic therapy (PDT) is a treatment for wet age-related macular degeneration (wet AMD). It is not used to treat dry AMD. […] Photodynamic therapy may be recommended if you can’t have injections of medicines to treat your AMD or if these injections don’t work. […] By limiting the growth of abnormal blood vessels under the macula, photodynamic therapy may help prevent the progression of wet AMD. It does not restore vision to eyes that have already been damaged. But it may help prevent further damage to the retina and further vision loss. […] PDT can lower the risk of severe vision loss by reducing the growth of and leakage from abnormal blood vessels under the retina. […] The effect of PDT in slowing the progress of AMD is often temporary, and the abnormal blood vessels begin leaking again after about 3 months. Most people need multiple treatments to get the full benefits of the therapy. […] A severe loss in visual clarity happens to some people who are treated with PDT. In some cases, vision partially recovers. […] Other side effects that may occur with PDT include: Temporary visual disturbances (abnormal vision, decreased vision, defects in the visual field).

• #2 Wet macular degeneration – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/wet-macular-degeneration/diagnosis-treatment/drc-20351113

  Photocoagulation. During photocoagulation therapy, an eye doctor uses a high-energy laser beam to seal problem blood vessels under the macula. This procedure helps stop the vessels from bleeding, with the aim of minimizing further damage to the macula. […] Few people who have wet macular degeneration get this treatment. It generally isn’t an option if you have problem blood vessels directly under the center of the macula. Also, the more damaged the macula is, the lower the likelihood of success. […] Low vision rehabilitation. Age-related macular degeneration doesn’t affect side vision and typically doesn’t cause total blindness. But it can reduce or eliminate central vision. You need central vision to read, drive and recognize people’s faces. It may help to get care from a low vision rehabilitation specialist, an occupational therapist, an eye doctor and others trained in low vision rehabilitation. They can help find ways to adapt to changing vision.

• #2 Age-Related Macular Degeneration (AMD) | Eye Care Specialists | Cape Girardeau, MO

  http://www.wespecialeyes.com/age-related-macular-degeneration/

  Anti-VEGF Treatment is currently the most common and effective treatment for wet macular degeneration. With this treatment, an anti-VEGF drug, such as Lucentis, Eylea, or Avastin, is injected into the eye with a very fine needle. The drug inhibits the development or leaking of the abnormal blood vessels slowing vision loss. […] Photodynamic Therapy (PDT) is a two-step, in-office procedure. First, Visudyne, a photo-sensitive drug, is injected into the blood stream through a vein in your arm. Visudyne attaches to molecules found in abnormal blood vessels allowing a special low-power, cool laser to target them in the macula. The drug activates when the laser fires and seals only the unwanted blood vessels without causing damage to the healthy ones. […] Thermal laser therapy cauterizes the abnormal blood vessels with a high-energy, focused beam of light which terminates the growth and prevents further leakage. This treatment is often used if the blood vessel growth is in a condensed area away from the center of the macula. Laser therapy helps prevent severe vision loss but leaves a permanent blind spot at the laser treatment point.

• #2

  https://www.aao.org/eye-health/tips-prevention/promising-new-treatments-amd

  „Today, more durable therapies are coming out, and treatments that may even cure the disease are in the works. Theres a lot of hope for people with AMD,” Sridhar says. […] Some of the most exciting research today explores alternatives to frequent injections. […] A new, higher-dose version of well-established anti-VEGF medicine Eylea may allow patients to go longer in between injections. […] Another new drug that targets two underlying causes of AMD has been FDA approved for both AMD and diabetic macular edema. […] Faricimab (Vabysmo), targets both VEGF and the protein angiopoietin-2. […] It may also be possible to combine two drugs and hit wet AMD with a double punch. […] Gene therapy is a promising alternative to ongoing eye injections of drugs such as Eylea, Lucentis, Vabysmo and Avastin.

• #2 Experimental gene therapy for wet age-related macular degeneration offers promise for older adults

  https://health.ucdavis.edu/news/headlines/experimental-gene-therapy-for-wet-age-related-macular-degeneration-offers-promise-for-older-adults/2024/01

  Wet age-related macular degeneration, or AMD, affects approximately 2 million people in the United States, Europe and Japan. It is a leading cause of vision loss among older adults. A new gene therapy being tested at UC Davis Health may offer a better treatment option. […] Ophthalmologists at UC Davis Health used an experimental gene therapy last summer to treat a patient with wet AMD. It was the first time the UC Davis Eye Center had used gene therapy. […] If approved, a gene therapy solution has the potential to maintain vision while reducing the number of injections by allowing the eye to continuously produce the medicine on its own, Yiu said. […] The treatment was part of a randomized, partially masked, controlled, phase 3 clinical study evaluating the efficacy and safety of an experimental therapy, ABBV-RGX-314, for wet AMD.

• #2 Experimental gene therapy for wet age-related macular degeneration offers promise for older adults

  https://health.ucdavis.edu/news/headlines/experimental-gene-therapy-for-wet-age-related-macular-degeneration-offers-promise-for-older-adults/2024/01

  ABBV-RGX-314 contains genetic instructions for making anti-VEGF proteins. After a single injection of ABBV-RGX-314 gene therapy, the eye can start to make the medicine on its own. […] Gene therapy for wet macular degeneration is potentially an exciting new therapy since it may reduce the burden of treatment, which presently requires regular visits to the ophthalmologist for frequent injections, Boxer said.

• #2 Age-related Macular Degeneration (AMD) — About Stem Cells

  https://www.aboutstemcells.org/info/macular-degeneration

  Researchers are taking several approaches to make RPE cells for transplantation. […] Some researchers are using induced pluripotent stem cells to grow RPE cells. […] Researchers are exploring different methods to deliver the replacement RPE cells to the eye, including creating patches of RPE cells in the lab. […] There are now several early-phase clinical trials planned or underway to test different approaches to generate and deliver lab-made RPE cells to the retina to treat AMD. […] Despite progress and encouraging clinical trial results, cell-based treatments for eye conditions are still experimental.

• #2 Age-Related Macular Degeneration Research Advances — Foundation Fighting Blindness

  https://www.fightingblindness.org/news/age-related-macular-degeneration-research-advances-821

  Luxa Biotechnology reported encouraging results for six patients with dry AMD receiving a low dose (50,000 cells) of RPESC-RPE-4W, its proprietary retinal pigment epithelial stem cell therapy, in a Phase 1/2a clinical trial. […] The Age-Related Eye Disease Study (AREDS) a landmark investigation conducted by the National Eye Institute (NEI) determined that antioxidant supplementation can slow the progression of AMD. […] The NEI recently completed a second AREDS study (AREDS2) to evaluate the potential benefits of the antioxidants lutein and zeaxanthin and the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). […] A new analysis of data from the National Eye Institutes (NEI) Age-Related Eye Disease Studies (AREDS and AREDS2) has shown that the AREDS nutritional supplements slowed the progression of geographic atrophy (GA), the late-stage of dry age-related macular degeneration (AMD) which is also known as geographic atrophy (GA).

• #2 Age-Related Macular Degeneration Research Advances — Foundation Fighting Blindness

  https://www.fightingblindness.org/news/age-related-macular-degeneration-research-advances-821

  Genentechs Susvimo, a permanent, refillable implant the size of a rice grain, provides continual delivery of an anti-VEGF treatment to the retina. […] Genentech, a global biotechnology company and member of the Roche Group, has shown that VabysmoTM (faricimab-svoa) is effective for for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). […] Regenerons wet AMD treatment, Eylea, blocks the development of unhealthy blood vessels that lead to vision loss. […] REGENXBIO, a clinical-stage gene therapy biotechnology company, is conducting two pivotal, Phase 3 clinical trials for RGX-314, its gene therapy designed to halt the growth of leaky blood vessels that cause retinal degeneration and central vision loss in people with the wet form of age-related macular degeneration (AMD).

• #2 Macular disease treatments – Macular Society

  https://www.macularsociety.org/diagnosis-treatment/treatments/

  The second is if the blood vessels that are causing the damage have been successfully suppressed and they are no longer leaking onto the macula. […] On rare occasions some people may be offered laser treatment. […] Researchers all over the world are working hard to find new and improved treatments for AMD. […] One area that is being highly researched is the development of longer acting drugs for wet AMD. […] Another way of reducing injections is an implant containing a drug reservoir. […] Research is also underway with the aim of moving away from the need for eye injections completely, but it is still in very early stages. […] Among the options being explored are treatments to reduce the inflammation thought to lead to dry AMD. […] Another promising approach is stem cell therapy. […] Clinical trials of stem cell therapies are underway for both wet and dry AMD.

• #2 Eyes – age-related macular degeneration | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/age-related-macular-degeneration

  Laser treatment this technique seals and destroys the leaking blood vessels. It may be recommended if the leaking blood vessels are located away from the centre of the macula. […] Photodynamic therapy a light-sensitive drug is injected into the veins in the arm and a specially designed laser is used to close off abnormal blood vessels in the retina. […] Various options are available to help manage AMD, including: Vision aids such as prescription glasses, magnifying glasses and telescopic devices to help the person live a more normal life. […] Occupational therapy can help the person to live a more independent life. […] Quitting smoking cigarette smoking contributes to the onset of AMD and can hasten its progression. It is important to stop smoking immediately. […] Lifestyle changes suggestions include eating a healthy diet and exercising regularly.

• #2 Age-related macular degeneration (AMD): Symptoms, treatment

  https://www.medicalnewstoday.com/articles/152105

  In 2022, the National Institutes of Health reported that the first person in the United States had received autologous stem cell therapy to treat dry AMD. […] IMT treatment might improve the vision of people with advanced AMD. It involves implanting a small device to help a person recover some vision and have more independence. […] A 2020 review suggests that some herbal and natural remedies may help prevent AMD, although there is not enough evidence to show that they will make a difference. […] For a person with AMD in one eye, dietary supplements may help prevent or slow the development of AMD in the other eye. […] AREDS 2 supplements consist of a special formulation for people who have or are at risk of AMD.

• #2 Macular Degeneration AMD | Retina Group of Washington | Wet & Dry AMD MD VA DC

  https://www.rgw.com/age-related-macular-degeneration-amd/

  Age Related Macular Degeneration (AMD) is the leading cause of vision loss for people over 60 years of age. AMD gradually destroys the central vision needed to see objects clearly and to perform common daily tasks. […] If Macular Degeneration is diagnosed early enough, we are very fortunate to have a number of possible treatment options that may help to slow or even halt the progression of vision loss. However, patients must understand that once the macula has been damaged, there is no treatment that currently can reverse that damage and the associated loss of vision. […] Avastin®, Eylea® and Lucentis® Injections are intravitreal injections-that means an injection that is placed directly into the Vitreous of the eye. Generally they need to be repeated every four to six weeks. Clinical studies of these anti-VEGF Injections indicate that when given to patients who have evidence of new blood vessel formation monthly, over 90% of patients will maintain their vision.

• #2 Diagnosis and Treatment – Moorfields Private

  https://www.moorfields.nhs.uk/private/eye-conditions-and-treatments/age-related-macular-degeneration-amd/diagnosis-and-treatment

  Age-related macular degeneration (AMD) is diagnosed by eye care specialists called optometrists. […] If AMD is suspected, you may be referred to an eye doctor (ophthalmologist) or specialist AMD service. […] Regular comprehensive eye exams, even without vision changes, are advised to detect early AMD before major vision loss occurs. Early detection and timely treatment are key to preserving sight threatened by AMD progression. […] Unfortunately, there are currently no dry macular degeneration treatment options available. […] Wet AMD is treated with anti-VEGF (vascular endothelial growth factor) injections into the eye. […] Photodynamic therapy (PDT) is sometimes added to anti-VEGF injections. […] Anti-VEGF drugs like ranibizumab (Lucentis) and bevacizumab (Avastin) are injected into the eye to treat conditions where abnormal blood vessels leak fluid under the retina at the back of the eye.

• #2 Macular Degeneration: Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/15246-macular-degeneration

  During this treatment, your provider will use a laser to seal and destroy the leaking blood vessels. […] Treatments for wet AMD carry some risk of complications, including eye infection, retinal detachment, structural eye damage, faster onset of cataracts, and severe vision loss. […] Age-related macular degeneration (AMD) is the leading cause of vision loss in older adults. Although AMD doesn’t cause complete blindness, the loss of central vision can make it harder to do everyday tasks. Dry macular degeneration, a condition that causes gradual vision loss, is the most common form. Taking nutritional supplements may slow the disease. Wet macular degeneration can cause rapid vision loss and may lead to legal blindness. Your eye care provider can offer treatments that may help preserve vision.

• #2 Dry macular degeneration – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/dry-macular-degeneration/diagnosis-treatment/drc-20350381

  For now, there’s no way to reverse damage from dry macular degeneration. However, there are many clinical trials in progress. If the condition is diagnosed early, you can take steps to help slow its progression, such as taking vitamin supplements, eating healthy and not smoking. […] For people with intermediate or advanced disease, taking a high-dose formulation of antioxidant vitamins and minerals may help reduce the risk of vision loss. […] The evidence doesn’t show benefit in taking these supplements for people with early-stage dry macular degeneration. Ask your eye doctor if taking supplements is right for you. […] Age-related macular degeneration doesn’t affect your side vision and typically doesn’t cause total blindness. But it can reduce or eliminate central vision. […] For some people with advanced dry macular degeneration in both eyes, an option to improve vision may be surgery to implant a telescopic lens in one eye. The telescopic lens, which looks like a tiny plastic tube, has lenses that magnify your field of vision. The telescopic lens implant may improve both distance and close-up vision, but it has a very narrow field of view.

• #3 Age-Related Macular Degeneration Treatment and Therapies – Eye & Ear Foundation of Pittsburgh

  https://eyeandear.org/2022/11/age-related-macular-degeneration-treatment-and-therapies/

  APL-2 C3 Inhibition (Apellis) […] Monthly or every other month intravitreal injections […] Phase III trials […] Reduction in geographic atrophy (GA) growth by 22%/16%. […] Zimura C5 Inhibition (IvericBio) […] Monthly intravitreal injections, 2 mg or 4 mg […] Phase III trials […] Reduction in GA growth by 27.4%/27.8%. […] Anti-Vascular Endothelial Growth Factor Intravitreal Injections […] Bevacizumab (Avastin) […] First used in 2004 […] Ranibizumab (Lucentis) […] Approved in 2006 […] Aflibercept (Eylea) […] Approved in 2012 […] Brolucizumab (Beovu) […] Approved in 2020 […] Faricimab (Vabysmo) […] Approved in 2022. […] New therapies are under development that affect metabolism: […] Drugs (Metformin, 8-OH-DPAT) […] Proteins (LIF, OSM) […] Gene Therapies (LIF, STAT3, PGC-1a).

• #3 Age-Related Macular Degeneration Research Advances — Foundation Fighting Blindness

  https://www.fightingblindness.org/news/age-related-macular-degeneration-research-advances-821

  The biopharmaceutical company Apellis received FDA approval to market SYFOVRE, a treatment for geographic atrophy (GA), the advanced from of dry age-related macular degeneration. […] Astellas has received FDA approval for IZERVAY (avacincaptad pegol) for the treatment of geographic atrophy (GA) secondary to advanced dry age-related macular degeneration. […] Ocugen has initiated a Phase 1/2 clinical trial of OCU-410, a modifier gene therapy designed to slow progression of the growth of lesions associated with geographic atrophy (GA). […] Regenerative Patch Technologies, a company developing stem-cell-derived treatments for people with retinal diseases, has reported encouraging results for the first five patients with advanced, dry age-related macular degeneration (AMD) participating in a Phase 1/2a clinical trial for its therapy a patch comprised of a layer of retinal pigment epithelial (RPE) cells on a synthetic scaffold.

Zobacz więcej